Most pharma stocks traded in the red during Friday’s session, with the Nifty Pharma index falling 2.19% at 21,854.15. Dr.

IST, the barometer index, the S&P BSE Sensex, shed 45.42 points or 0.07% to 76,474.96. The Nifty 50 index fell 20.60 points or 0.09% to 23,184.75.

The company's North American revenue has seen a decline of over 9%. One of the primary worries is the reduction in revenues ...

Prabhudas Lilladher recommended reduce rating on Dr. Reddy's Laboratories with a target price of Rs 1335 in its research ...

Welcome to the Dr Reddys Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock.

Dr Reddy's Laboratories Ltd (RDY) reports a robust 16% YoY revenue growth, driven by strategic product launches and market ...

Silver prices climbed Rs 751 on the Multi Commodity Exchange, reaching Rs 91,900 per kg due to increased bets by participants ...

Axis Securities has downgraded Hindustan Unilever to ‘hold’ rating with a target price of Rs 2,520 (+8%).

Dr Reddy’s Labs & Dr Reddy’s Foundation announce launch of soil testing resource centre in Hyderabad: Our Bureau, Mumbai: Dr Reddys ...

Although Dr Reddy's Laboratories' Q3 earnings slightly exceeded analysts' expectations, the main point of concern was the ...

(Reuters) -Shares of Dr Reddy's Laboratories dropped 6% on Friday and were on track for their worst session in nearly nine ...

CEO of Dr Reddy's Laboratories, Erez Israeli believes his company's affordable medicines benefit the U.S. market and will be ...